Vasopressin or Epinephrine for Out-of-Hospital Cardiac Arrest

Annals of Emergency Medicine

Volumn 48, Issue 1, 2006, Pages 86-97

  Wyer, Peter C ^a   Perera, Phillips ^a   Jin, Zhezhen ^b   Zhou, Qi ^c   Cook, Deborah J ^c   Walter, Stephen D ^c   Guyatt, Gordon H ^c  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b Columbia University ^*  (United States)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; VASOPRESSIN;

ARTICLE; ASYSTOLE; CLINICAL TRIAL; COCHRANE LIBRARY; COMPARATIVE STUDY; DATA BASE; DEFIBRILLATION; EMBASE; EMERGENCY MEDICINE; EVIDENCE BASED MEDICINE; HEART ARREST; HEART RHYTHM; HOSPITAL DISCHARGE; HUMAN; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL; SYSTEMATIC REVIEW;

BRAIN DAMAGE, CHRONIC; EMERGENCY MEDICAL SERVICES; EPINEPHRINE; EVIDENCE-BASED MEDICINE; HEART ARREST; HUMANS; ODDS RATIO; PATIENT DISCHARGE; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RESUSCITATION; SURVIVAL ANALYSIS; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 33744977922     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2005.11.024     Document Type: Article

References (38)

1. Wyer P.C., Rowe B.H., Guyatt G.H., et al. The clinician and the medical literature. when can we take a shortcut?. Ann Emerg Med 36 (2000) 149-155
2. Dorian P., Cass D., Schwartz B., et al. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 346 (2002) 884-890
3. Kudenchuk P.J., Cobb L.A., Copass M.K., et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 341 (1999) 871-878
4. Guyatt G., Montori V., Devereaux P.J., et al. Patients at the center. in our practice, and in our use of language. ACP J Club 140 (2004) A11-A12
5. Bucher H., Guyatt G., Cook D., et al. Therapy and applying the results. surrogate outcomes. In: Guyatt G., and Rennie D. (Eds). Users' Guides to the Medical Literature. A Manual for Evidence-Based Clinical Practice (2002), American Medical Association, Chicago, IL 393-413
6. Vandycke C., and Martens P. High dose versus standard dose epinephrine in cardiac arrest. a meta-analysis. Resuscitation 45 (2000) 161-166
7. Wiley InterScience. The Cochrane library. Available at: http://www3.interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME. Accessed June 1, 2005.
8. The Center for Medical Education. Emergency medical abstracts. Available at: http://ccme.org. Accessed June 1, 2005.
9. American Heart Association. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care, part 6. advanced cardiovascular life support. Circulation 102 suppl (2000) I86-I166
10. Lindner K.H., Dirks B., Strohmenger H.U., et al. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 349 (1997) 535-537
11. Wenzel V., Krismer A.C., Arntz H.R., et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med 350 (2004) 105-113
12. Stiell I.G., Hebert P.C., Wells G.A., et al. Vasopressin versus epinephrine for inhospital cardiac arrest. a randomised controlled trial. Lancet 358 (2001) 105-109
13. Biondi-Zoccai G.G.L., Abbate A., Parisi Q., et al. Is vasopressin superior to adrenaline or placebo in the management of cardiac arrest? a meta-analysis. Resuscitation 59 (2003) 221-224
14. Jacobs I., and Finn F. Adrenaline and Vasopressin for Cardiac Arrest (Protocol). The Cochrane Library (2004), John Wiley & Sons, Chichester, UK
15. Hogg K. Vasopressin or adrenaline in cardiac resuscitation [BestBETs Web site]. Available at: http://www.bestbets.org/cgi-bin/bets.pl?record=00407. Accessed March 2, 2004.
16. Aung K., and Htay T. Vasopressin for cardiac arrest. Arch Intern Med 165 (2005) 17-24
17. Lee C.C., Jung Y.S., Yoon S.K., et al. Vasopressin administration in out-of-hospital cardiac arrest. [abstract]. Ann Emerg Med 36 (2000) S91
18. Li P.J., Chen T.T., Zhang J.M., et al. Clinical study on administration of vasopressin during closed chest cardiopulmonary resuscitation. Chinese Crit Care Med 11 (1999) 28-31
19. Hopewell S., McDonald S., Clarke M., et al. Grey literature in meta-analyses of randomized trials of health care interventions. The Cochrane Database of Methodology Reviews (2002) Issue 4
20. Cook D.J., Guyatt G.H., Ryan G., et al. Should unpublished data be included in meta-analyses?. JAMA 269 (1993) 2749-2753
21. McAuley L., Pham B., Tugwell P., et al. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?. Lancet 356 (2000) 1228-1231
22. Juni P., Holenstein F., Sterne J., et al. Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?. Int J Epidemiol 31 (2002) 115-123
23. Fergusson D., Laupacis A., Salmi L.R., et al. What should be included in meta-analyses? an exploration of methodological issues using the ISPOT meta-analyses. Int J Technol Assess Health Care 16 (2000) 1109-1119
24. Jennett B., and Bond M. Assessment of outcome after severe brain damage. a practical scale. Lancet 1 (1973) 480-484
25. The Brain Resuscitation Clinical Trial II Study Group. A randomized clinical trial of calcium entry blocker administration to comatose survivors of cardiac arrest. design, methods, and patient characteristics. Control Clin Trials 12 (1991) 525-545
26. Nesbitt L.P., Stiell I.G., Cousineau D., et al. Is the cerebral performance category score a valid measure of functional outcome after out-of-hospital cardiac arrest?. Acad Emerg Med 12 (2005) 71 [abstract]
27. Feeny D., Farris K., Cote I., et al. A cohort study found the RAND-12 and Health Utilities Index Mark 3 demonstrated construct validity in high-risk primary care patients. J Clin Epidemiol 58 (2005) 138-141
28. Guyatt G., Cook D., Devereaux P.J., et al. Therapy. In: Guyatt G., and Rennie D. (Eds). Users' Guides to the Medical Literature. A Manual of Evidence-Based Clinical Practice (2002), American Medical Association, Chicago, IL 55-79
29. Fleiss J.L. The statistical basis of meta-analysis. Stat Methods Med Res 2 (1993) 121-145
30. DerSimonian R., and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7 (1986) 177-188
31. Montori V., Guyatt G., Oxman A., et al. Summarizing the evidence. fixed-effects and random-effects models. In: Guyatt G., and Rennie D. (Eds). Users' Guides to the Medical Literature. A Manual for Evidence-Based Clinical Practice (2002), American Medical Association, Chicago, IL 539-545
32. Higgins J.P.T., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
33. Higgins J.P.T., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
34. Montori V., Hatala R., and Guyatt G. Summarizing the evidence. evaluating differences in study results. In: Guyatt G., and Rennie D. (Eds). Users' Guides to the Medical Literature. A Manual for Evidence-Based Clinical Practice (2002), American Medical Association, Chicago, IL 547-552
35. Oxman A.D., and Guyatt G.H. A consumer's guide to subgroup analyses. Ann Intern Med 116 (1992) 78-84
36. Oxman A., and Guyatt G. Summarizing the evidence. when to believe a subgroup analysis. In: Guyatt G., and Rennie D. (Eds). Users' Guides to the Medical Literature. A Manual for Evidence-Based Clinical Practice (2002), American Medical Association, Chicago, IL 553-565
37. McIntyre K.M. Vasopressin in asystolic cardiac arrest. N Engl J Med 350 (2004) 179-181
38. Teng E.L., and Chui H.C. The modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48 (1987) 314-318